Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
The current Gilead Sciences(GILD) stock price is $133.24, with a market capitalization of 164.84B. The stock trades at a price-to-earnings (P/E) ratio of 18.55 and offers a dividend yield of 2.36%.
On 2026-07-29, Gilead Sciences(GILD) stock moved within a range of $132.57 to $134.73. With shares now at $133.24, the stock is trading +0.5% above its intraday low and -1.1% below the session's peak.
Trading volume for Gilead Sciences(GILD) stock has reached 7.76M, versus its average volume of 6.03M.
Over the past 52 weeks, Gilead Sciences(GILD) stock has traded between a high of $157.29 and a low of $108.46.
Over the past 52 weeks, Gilead Sciences(GILD) stock has traded between a high of $157.29 and a low of $108.46.
GILD News
Gilead Sciences (GILD) is in focus after the European Medicines Agency’s Committee for Medicinal Products for Human Use backed the use of Trodelvy plus Keytruda...
Healthcare investors are watching AstraZeneca closely after fresh comments about operating at Chinese speed, reaffirming a 2030 sales goal of $80b and reporting...
The European Medicines Agency’s CHMP has issued a positive opinion for Trodelvy plus Keytruda in first line treatment of PD-L1 positive metastatic triple negati...
Analyst ratings
79%
of 29 ratingsMore GILD News
In the latest trading session, Gilead Sciences (GILD) closed at $69.61, marking a -1.58% move from the previous day. This move lagged the S&P 500's daily gain o...
Gilead (GILD) Sciences announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has adopted a posit...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.